LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma
Nicoletta Colombo, Kenichi Harano, Emma Hudson, Francesca Galli, Yoland Antill, Chel Hun Choi, Manuela Rabaglio, Frederik Marmé, Edgar Petru, Chien‐Hung Lai, Elena Biagioli, L. Fariñas Madrid, Kazuhiro Takehara, K. Allan, Y.C. Lee, Elisa Piovano, Claudio Zamagni, Giulia Tasca, Annamaria Ferrero, M.P. Barretina Ginesta
Topics & Concepts
MedicineCarboplatinAtezolizumabPaclitaxelPlaceboOncologyChemotherapyInternal medicineEndometrial cancerRandomized controlled trialCarcinomaImmunotherapyGynecologyCancerCisplatinPembrolizumabPathologyAlternative medicineEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersCancer Cells and Metastasis